Search Result

Results for "

7424 hcl armohib 28 Inhibitors

" in MCE Product Catalog:

By Targets:	Adenosine Deaminase (1) Antibody-Drug Conjugates (ADCs) (1) Apoptosis (1) CD22 (1) Fluorescent Dye (1)
By Research Areas:	Cancer (2) Cardiovascular Disease (1)

Inhibitors & Agonists

Targets Recommended: CD28

Cat. No.	Product Name	Target	Research Areas

Moxetumomab pasudotox CAT 8015; HA 22; Anti-Human CD22 Recombinant Antibody	Antibody-Drug Conjugates (ADCs) CD22	Cancer
Moxetumomab pasudotox (CAT 8015) is anti-CD22 immunotoxin containing an anti-CD22 F_v and Pseudomonas exotoxin. CD22 is a cell surface receptor expressed on a variety of malignant B-cells. Moxetumomab pasudotox can be used in the research of hairy cell leukemia (HCL).

Naphthoresorcinol 1,3-Dihydroxynaphthalene	Fluorescent Dye	Others
Naphthoresorcinol (1,3-Dihydroxynaphthalene) is a fluorescent dye (λ_ex=330 nm, λ_em=380 nm) that can react with the NPPD (a tracer) and concentrated HCl and develop a red color. Naphthoresorcinol could be used as a background electrolyte (BGE) to determine the carbohydrates.

Cladribine 2-Chloro-2′-deoxyadenosine; CldAdo; 2CdA	Adenosine Deaminase Apoptosis	Cardiovascular Disease Cancer
Cladribine (2-Chloro-2′-deoxyadenosine), a purine nucleoside analog, is an orally active adenosine deaminase inhibitor. Cladribine functions as an inhibitor of DNA synthesis to block the repair of the damaged DNA. Cladribine can inhibit DNA methylation. Cladribine has anti-lymphoma activity. Cladribine can be used for the research of several hematologic malignancies and multiple sclerosis.

Cat. No.	Product Name	Type

Naphthoresorcinol 1,3-Dihydroxynaphthalene	Fluorescent Dyes/Probes
Naphthoresorcinol (1,3-Dihydroxynaphthalene) is a fluorescent dye (λ_ex=330 nm, λ_em=380 nm) that can react with the NPPD (a tracer) and concentrated HCl and develop a red color. Naphthoresorcinol could be used as a background electrolyte (BGE) to determine the carbohydrates.

Cat. No.	Product Name	Target	Research Area

Moxetumomab pasudotox CAT 8015; HA 22; Anti-Human CD22 Recombinant Antibody	Antibody-Drug Conjugates (ADCs) CD22	Cancer
Moxetumomab pasudotox (CAT 8015) is anti-CD22 immunotoxin containing an anti-CD22 F_v and Pseudomonas exotoxin. CD22 is a cell surface receptor expressed on a variety of malignant B-cells. Moxetumomab pasudotox can be used in the research of hairy cell leukemia (HCL).

Cat. No.	Product Name	Species	Source

RANKL/TNFSF11 Protein, Human rHuRANK L/TNFSF11; TRANCE; CD254	Human	E. coli
RANKL (TNFSF11), a type II transmembrane protein, is a receptor ligand for NF-κB (RANK). RANKL is an activator of NF-κB. When binding to NF-κB, it induces the differentiation of monocyte/macrophage-lineage cells into osteoclasts and leads to osteoclast precursor maturation. RANKL is critical for osteoclasts maturation, bone modeling, and bone remodeling, as well as the development of lymph nodes (LNs). RANKL/TNFSF11 Protein, Human is a recombinant human RANKL (I140-D317) without any tag, which is produced in E.coli.

VEGF-C Protein, Human (116a.a, HEK293) rHuVEGF-C; Vascular endothelial growth factor C; Flt4-L; VRP	Human	HEK293
VEGF-C Protein, Human (116a.a, HEK293) functions in lymphangiogenesis, where it acts on lymphatic endothelial cells (LECs) primarily via its receptor VEGFR-3 promoting survival, growth and migration.

HY-P70501

VEGF-C Protein, Human (196a.a, HEK293, His)
Vascular Endothelial Growth Factor C; VEGF-C; Flt4 Ligand; Flt4-L; Vascular Endothelial Growth Factor-Related Protein; VRP; VEGFC
Human HEK293
HY-P73529

VEGF-C Protein, Human (125a.a, HEK293, His)
Flt4-L; vascular endothelial growth factor C; VEGFC; VRP
Human HEK293
HY-P7313A

VEGF-C Protein, Human (116a.a, HEK293, His)
rHuVEGF-C; Vascular endothelial growth factor C; Flt4-L; VRP
Human HEK293

Name
Email *

	Sorry, but the email address you supplied was invalid.